Format

Send to

Choose Destination
Dev Cell. 2019 May 6;49(3):361-374. doi: 10.1016/j.devcel.2019.04.010.

Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.

Author information

1
Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
2
Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA. Electronic address: ykang@princeton.edu.

Abstract

Epithelial-to-mesenchymal transition (EMT) and its reversed process, mesenchymal-to-epithelial transition (MET), are fundamental processes in embryonic development and tissue repair but confer malignant properties to carcinoma cells, including invasive behavior, cancer stem cell activity, and greater resistance to chemotherapy and immunotherapy. Understanding the molecular and cellular basis of EMT provides fundamental insights into the etiology of cancer and may, in the long run, lead to new therapeutic strategies. Here, we discuss the regulatory mechanisms and pathological roles of epithelial-mesenchymal plasticity, with a focus on recent insights into the complexity and dynamics of this phenomenon in cancer.

KEYWORDS:

cellular plasticity; chemoresistance; epithelial-to-mesenchymal transition; immune evasion; metastasis; stemness

PMID:
31063755
PMCID:
PMC6506183
[Available on 2020-05-06]
DOI:
10.1016/j.devcel.2019.04.010

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center